Join to View Full Profile
1700 Hospital South DrSte 300Austell, GA 30106
Phone+1 770-944-2830
Fax+1 678-581-7170
Dr. Osmon is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Carlos Osmon is an oncologist in Roswell, GA and is affiliated with multiple hospitals in the area, including WellStar Cobb Hospital, WellStar Douglas Hospital, WellStar Kennestone Hospital, and Wellstar West Georgia Medical Center. He received his medical degree from Universidad Nacional de La Plata Faculty of Medicine and has been in practice 49 years.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1975 - 1977- Emory University School of MedicineResidency, Internal Medicine, 1974 - 1975
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1971 - 1974
Universidad Nacional de La Plata Faculty of MedicineClass of 1968
Certifications & Licensure
IL State Medical License 1974 - Present
GA State Medical License 1974 - 2027
NC State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2012, 2014-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 3 citationsPhase Ii trial of 5-fluorouracil, folinic acid and recombinant α-2a-interferon in patients with advanced colorectal cancerFarhad Ravandi, Michael Rytting, Carlos Osmon, Edward L. Braud, Ralph W. Roach
Anti-Cancer Drugs. 1999-07-01
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
